Peripartum HFpEF: Identification of a Novel Phenotype and the Need for Cardio-Obstetrics Management
- PMID: 38939402
- PMCID: PMC11198047
- DOI: 10.1016/j.jacadv.2023.100799
Peripartum HFpEF: Identification of a Novel Phenotype and the Need for Cardio-Obstetrics Management
Keywords: HFpEF; heart failure; peripartum cardiomyopathy.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures

References
-
- American College of Obstetricians and Gynecologists’ Presidential Task Force on Pregnancy and Heart Disease. Committee on Practice Bulletins—Obstetrics ACOG practice Bulletin No. 212: pregnancy and heart disease. Obstet Gynecol. 2019;133:e320–e356. - PubMed
-
- Bauersachs J., König T., van der Meer P., et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2019;21:827–843. - PubMed
-
- Sliwa K., Hilfiker-Kleiner D., Petrie M.C., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2010;12:767–778. - PubMed
-
- Mehta L.S., Warnes C.A., Bradley E., et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020;141:e884–e903. - PubMed
Publication types
LinkOut - more resources
Full Text Sources